发明名称 |
GLYCOCONJUGATE VACCINES FOR USE IN IMMUNE-COMPROMISED POPULATIONS |
摘要 |
andglycoconjugate vaccines are disclosed for use in preventing or treating bacterial infection in an immune-compromised individual. Such vaccines contain an immunocarrier and a conjugate of a polysaccharide or glycopeptide surface antigen from a clinically-significant bacterial strain. The vaccines can be used for active protection in immune-compromised individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure.
|
申请公布号 |
KR20100044265(A) |
申请公布日期 |
2010.04.29 |
申请号 |
KR20107005839 |
申请日期 |
2002.09.19 |
申请人 |
NABI BIOPHARMACEUTICALS |
发明人 |
FATTOM ALI I.;NASO ROBERT B. |
分类号 |
A61K39/116;A61K39/085;A61P31/04;A61P37/02 |
主分类号 |
A61K39/116 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|